32
Active Trials
19
Phase 1
6
Phase 2
11
Phase 3
4
Therapeutic Areas
Portfolio Concentration: 116% of active trials in Oncology
Oncology
37 active / 37 total
Solid Tumor (Advanced)
12 active
12 total since 2015
CLL
9 active
6 Ph3
9 total since 2015
Non-Hodgkin Lymphoma
7 active
4 Ph3
7 total since 2015
Breast Cancer
2 active
2 total since 2015
Gastric Cancer
2 active
1 Ph3
2 total since 2015
HER2- Breast Cancer
2 active
1 Ph3
2 total since 2015
Hepatocellular Carcinoma
1 active
1 total since 2015
NSCLC
1 active
1 total since 2015
Multiple Myeloma
1 active
1 total since 2015
Immunology
5 active / 5 total
Cardiovascular
2 active / 2 total
Urology
1 active / 1 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)